Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
FDA panel recommends OK for STAAR's ICL
Monrovia, CA-The FDA's Ophthalmic Devices Panel of the Center for Devices and Radiological Health is recommending that STAAR Surgical Co.'s Implantable Contact Lens (ICL) be approved with conditions for use in correcting ?3 to ?15 D of myopia and reducing myopia in the range of ?15 to ?20 D.
Related Videos
Related Content
